Based on these observations, and considering the previously reported similarity between HSP60 and AChR-α [30], we assessed anti-HSP60 antibodies that were potentially cross-reacting with AChR-α, in AChR-MG patients and healthy controls. This evidence concerns the gene CHRNA1 and myasthenia gravis.